These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 36058780)
21. Pain in sickle cell disease: current and potential translational therapies. Sagi V; Mittal A; Tran H; Gupta K Transl Res; 2021 Aug; 234():141-158. PubMed ID: 33711512 [TBL] [Abstract][Full Text] [Related]
22. A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease. Matthie N; Ross D; Sinha C; Khemani K; Bakshi N; Krishnamurti L J Natl Med Assoc; 2019 Apr; 111(2):158-168. PubMed ID: 30266214 [TBL] [Abstract][Full Text] [Related]
24. A Patient Presents for Dental Extraction and Goes into Sickle Cell Crisis in the Dental Chair. Hong WW; Kim IH; Dayo AF; Mupparapu M Dent Clin North Am; 2023 Oct; 67(4):679-682. PubMed ID: 37714623 [TBL] [Abstract][Full Text] [Related]
25. Outcomes of an Emergency Department Observation Unit-Based Pathway for the Treatment of Uncomplicated Vaso-occlusive Events in Sickle Cell Disease. Lyon M; Sturgis L; Lottenberg R; Gibson ME; Eck J; Kutlar A; Gibson RW Ann Emerg Med; 2020 Sep; 76(3S):S12-S20. PubMed ID: 32928457 [TBL] [Abstract][Full Text] [Related]
26. Neuropathic pain in sickle cell disease: measurement and management. Glaros A; Brandow AM Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):553-561. PubMed ID: 33275730 [TBL] [Abstract][Full Text] [Related]
27. Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease. Russo K; Chhunchha P J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):116-122. PubMed ID: 36701332 [TBL] [Abstract][Full Text] [Related]
28. Randomized phase 2 trial of Intravenous Gamma Globulin (IVIG) for the treatment of acute vaso-occlusive crisis in patients with sickle cell disease: Lessons learned from the midpoint analysis. Manwani D; Xu C; Lee SK; Amatuni G; Cohen HW; Carullo V; Morrone K; Davila J; Shi PA; Ireland K; Keenan J; Frenette PS Complement Ther Med; 2020 Aug; 52():102481. PubMed ID: 32951731 [TBL] [Abstract][Full Text] [Related]
29. A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive Crisis. Moody K; Abrahams B; Baker R; Santizo R; Manwani D; Carullo V; Eugenio D; Carroll A J Pain Symptom Manage; 2017 Jun; 53(6):1026-1034. PubMed ID: 28192225 [TBL] [Abstract][Full Text] [Related]
30. Use of gabapentin in the treatment of chronic pain in an adolescent with sickle cell disease. Correia CR; Soares AT; Azurara L; Palaré MJ BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28432164 [TBL] [Abstract][Full Text] [Related]
31. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease. Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617 [TBL] [Abstract][Full Text] [Related]
32. An innovative intervention for the prevention of vaso-occlusive episodes in sickle cell disease. Jeon WJ; Joung B; Moon JH; Hino C; Park D; Pham B; Castillo DR; Chong E; Kaur S; Grismore C; Cao H Hematology; 2023 Dec; 28(1):2215575. PubMed ID: 37227254 [TBL] [Abstract][Full Text] [Related]
33. Managing Acute Complications Of Sickle Cell Disease In Pediatric Patients. Subramaniam S; Chao JH Pediatr Emerg Med Pract; 2016 Nov; 13(11):1-28. PubMed ID: 27775898 [TBL] [Abstract][Full Text] [Related]
34. Presentation of Acute Pancreatitis in Sickle Cell Disease Patients: A Single Hospital Experience. Al-Hindi S; Khalaf Z; Al-Sousi AN Afr J Paediatr Surg; 2024 Jul; 21(3):151-154. PubMed ID: 39162749 [TBL] [Abstract][Full Text] [Related]
35. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219 [TBL] [Abstract][Full Text] [Related]
36. Sickle Cell Disease: A Review of Nonpharmacological Approaches for Pain. Williams H; Tanabe P J Pain Symptom Manage; 2016 Feb; 51(2):163-77. PubMed ID: 26596876 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease. Pinto VM; Gianesin B; Sardo S; Mazzi F; Baiardi G; Menotti S; Piras F; Quintino S; Robello G; Mattioli F; Finco G; Forni GL; De Franceschi L Orphanet J Rare Dis; 2024 Jan; 19(1):22. PubMed ID: 38254184 [TBL] [Abstract][Full Text] [Related]
38. Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches. Xu JZ; Thein SL Blood; 2022 May; 139(20):3030-3039. PubMed ID: 35587865 [TBL] [Abstract][Full Text] [Related]
39. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study. Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103 [TBL] [Abstract][Full Text] [Related]
40. Sickle cell disease: an update. Conway O'Brien E; Ali S; Chevassut T Clin Med (Lond); 2022 May; 22(3):218-220. PubMed ID: 35584832 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]